Mesenchymal Stem Cell (MSCT) Clinical Trials – Multiple Sclerosis News Today
Multiple Sclerosis News Today |
Mesenchymal Stem Cell (MSCT) Clinical Trials
Multiple Sclerosis News Today Autologous mesenchymal stem cells, commonly called MSCs, have been shown to induce immunologic and neurologic effects (neuroregenerative and neuroprotective) in animal models. Autologous transplant means that the cells are taken from then … |
